Mental Health Issues Triple Among UK Students

Updated Feb 20, 2025 | 08:55 AM IST

SummaryAs per the latest data, the number of mental health cases tripled among students in the UK. The worse affected are LGBTQ students and women.
Mental Health Issues Triple Among UK Students

Credits: Canva

As per the latest data released by Transforming Access to Student Outcomes in Higher Education (TASO) and the Policy Institute at King's College London, the number of UK students reporting mental health difficulties tripled. The estimate reveals that around 300,000 students could now be experiencing mental health struggles. Of the total, 18% of students reported some kind of mental health issue in 2024.

As per the reports, this estimate is triple what was reported in 2017, where it was at 6%. Experts also say that Covid-19 pandemic is "often considered to have contributed to this, it does not explain the ongoing rise in mental health difficulties." Another reason could also be the "changing definition and increasing openness about mental health" which has led to a rise in numbers. The report notes, "This trend pre-dates the Covid-19 pandemic and the cost-of-living crisis. Although these factors play a part in students' deteriorating mental health, they cannot therefore be the only explanation."

How Did The Report Conclude?

The report drew data collected over the latest Student Academic Experience Survey of 93,212 students. From the survey, it was found that there exist significant disparities between demographic groups, with women being twice as likely to report mental health difficulties, about 22% as compared to men, at 11%.

What Did The Results Reveal?

The results revealed that students who identified as LGBTQ experienced the highest rates of mental health challenges. This has actually lessened the hope that conditions for LGBTQ students are improving, which may not have been a positive case.

Of them, 42% are bisexual and lesbian students, whereas last year it was 35% and 32% respectively. The report also noted that mental health difficulties among lesbian women and gay men rose three times the rate of straight people, and among bisexual and asexual people, it was twice as high. For trans students, the number jumped from 25% in 2023 to 40% in 2024.

Is The LGBTQ+ Prone To Mental Health Crisis?

As per the Child Mind Institute, being LGBTQ+ does not cause mental health problems, but because these kids often face factors like rejection, discrimination and violence, they are at a higher risk of challenges including depression, anxiety, and even attempting suicide.

A UTAH Health study quotes Anna Docherty, PhD, LP, assistant professor of psychiatry at Huntsman Mental Health Institute that, "likely with any identity, feeling different - or worse, unaccepted as you are is a significant risk factor of mental health struggle." The data reveals that LGBTQ+ teens are six times more likely to experience symptoms of depression than non-LGBTQ+ identifying teens. They are also more than twice as likely to feel suicidal and more than four times as likely to attempt suicide. In the US alone, 48% of transgender adults report that they have considered suicide in the last year, compared to 4% of the overall population.

What Do These Findings Mean?

TASO's academic lead and professor of public policy at King's College London, Michael Sanders said, "LGBTQ students and women bear the brunt of the rise in declining mental health and urgent action is needed to understand and address these trends."

End of Article

Health Canada Warns Against Faulty Radon Detectors: How The Invisible Gas In Your Home May Cause Lung Cancer

Updated Nov 17, 2026 | 09:04 PM IST

SummaryHealth Canada issued a warning against radon exposure after identifying faulty radon detectors sold online. Long-time radon exposure may cause lung cancer.
Health Canada Warns Against Faulty Radon Detectors: How The Invisible Gas In Your Home May Cause Lung Cancer

Credit: AI-generated image

Faulty radon detectors have sparked concern after Health Canada issued a warning about how inaccurate readings on devices sold online could mislead consumers. The advisory issued recently says that faulty detectors could underestimate radon levels, giving consumers a false sense of security about their exposure to the cancer-causing gas.

It talks about electronic radon monitors and home-testing kits that have previously recalled after it was found that they gave inaccurate readings.

Among the products Health Canada has previously warned against are the InkBird WiFi Radon Detector (model RD-2), Life Basis radon detectors, Hanchen Home Radon Detector and Spolehli radon detectors. The agency has also issued warnings about other radon-monitoring devices sold online.

Inaccurate readings can be problematic in both ways. A detector may report radon levels lower than they actually are, leaving people exposed to dangerous concentrations without their knowledge. On the other hand, it may report higher levels than those present, causing unnecessary panic.

Health Canada recommends that consumers choose electronic radon monitors that have passed performance testing by the Canadian National Radon Proficiency Program (C-NRPP).

What Is Radon And How Does It Enter Your Home?

Also read: Trials For Deadly Childhood Brain Cancer Stalled After Trump Administration Shuts Down 27-Year Research Consortium

Radon is a naturally occurring radioactive gas released when uranium in soil and rocks breaks down. It is invisible, odourless and tasteless, making it impossible to detect without specialised equipment.

The gas can enter buildings through cracks in foundations, gaps around pipes, floor drains and other openings.

While radon disperses quickly in outdoor air, it can accumulate to high concentrations indoors, especially basements and poorly-ventilated areas.

Long-term exposure to highradon levels increases the risk of lung cancer. According to Health Canada, radon is the second-leading cause of lung cancer in Canada after smoking and the leading cause among people who have never smoked.

The risk depends on both the concentration of radon in the air and how long a person is exposed. People who smoke and are exposed to radon face an even greater risk of lung cancer.

Radon Exposure & Lung Cancer

Also read: Daraxonrasib: Europe Approves First RAS-Targeted Drug For Metastatic Pancreatic Cancer

Radon decays into radioactive particles that can be inhaled through breathing. These particles release radiation that can damage the DNA of lung cells. Long-time exposure can lead to genetic changes that contribute to cancer.

The International Agency for Research on Cancer (IARC) classifies radon as a Group 1 carcinogen, meaning there is sufficient evidence that it causes cancer in humans.

How To Check Radon Levels In Your Home?

Health Canada recommends long-term testing to determine the average radon concentration in your home. A test lasting at least three months provides a more reliable assessment than short-term measurements because radon levels can fluctuate with weather, ventilation and seasonal changes.

Consumers should:

  • Choose a long-term radon testing kit that has passed C-NRPP performance testing.
  • Place the detector on the lowest level of the home that is regularly occupied like the basement.
  • Keep the device away from windows, doors, heating sources and ventilation outlets.
  • Continue testing for at least three months before interpreting the average result.

Health Canada's guideline for indoor radon is 200 becquerels per cubic metre (Bq/m³). If the average level is above this threshold, homeowners should take action within one year and consult a certified professional.

End of Article

Trials For Deadly Childhood Brain Cancer Stalled After Trump Administration Shuts Down 27-Year Research Consortium

Updated Nov 17, 2026 | 06:00 PM IST

SummaryPediatric Brain Tumor Consortium (PBTC)'s shutdown has impacted multiple clinical trials and research of aggressive childhood brain cancer like diffuse intrinsic pontine glioma (DIPG) and ependymoma.
Trials For Deadly Childhood Brain Cancer Stalled After Trump Administration Shuts Down 27-Year Research Consortium

Credit: AI-generated image

Clinical trials investigating experimental treatments for rare, aggressive childhood brain cancers have been disrupted after the closure of a US research consortium that was in operation for 27 years.

The shutdown of the Pediatric Brain Tumor Consortium (PBTC), after the National Cancer Institute (NCI) declined to renew its funding, has caused significant delays and rendered desperate families searching for alternative treatment options.

The consortium was composed of 16 leading children's hospitals and academic medical centres across the US, aiming to investigate new treatments for aggressive brain tumours, including diffuse intrinsic pontine glioma (DIPG) and ependymoma.

The NCI informed consortium leaders about the decision in August 2025, ending its approximately $4 million annual grant. Eight ongoing clinical trials were subsequently halted, according to The New York Times.

The consortium formally dissolved in September 2026. Researchers say the disruption has affected not only ongoing studies but also the infrastructure and resources needed to develop new treatments for childhood brain cancers.

DIPG Is One Of The Most Aggressive Childhood Brain Cancers

Also read: Losing Balance While Walking? Doctors Explain When It Could Be A Neurological Warning Sign

DIPG is a rare, aggressive brain tumour that usually affects children between four and 10 years of age. It develops in the pons, a part of the brainstem which is responsible for essential functions like breathing, heart rate, coordination and balance.

Since the tumour grows within critical brain tissue and spreads through the brainstem, it cannot be removed through surgery. Clinicians describe it “like sand in grass”.

Radiation therapy is commonly used to fight the tumour but its benefits are temporary. There is currently no established treatment. The average survival after diagnosis is approximately nine to 12 months.

With limited treatment options, clinical trials investigating experimental therapies are a need of the hour for children suffering from DIPG.

Research And Clinical Trials That Were Affected Due To Funding Closure

Also read: AIIMS Delhi Performs India's First Open Fetal Surgery To Repair Spina Bifida

The closure disrupted several studies exploring experimental treatments for childhood brain tumours.

One of the affected studies, PBTC-059, was a Phase 1 trial investigating CAR-T cell therapy in children with ependymoma. CAR-T therapy entails modifying a patient's immune cells to identify and attack cancer cells.

Another study, PBTC-N14, was discontinued too. Researchers at Memorial Sloan Kettering Cancer Center were investigating whether cerebrospinal fluid samples could provide genetic information similar to that obtained through an invasive brain biopsy, reducing the need for surgery in some children.

Researchers were also exploring other experimental options for DIPG, including cancer vaccines and devices that can deliver electrical stimulation to the brain.

According to the NCI's updated information, some paused trials are expected to reopen to patient enrolment in late 2026 or early 2027. But the interruption has created a significant gap and delay for families who were previously able to access these trials.

27 Years Of Research Data At Stake

Also read: Beth Dobbin's Myalgic Encephalomyelitis Campaign Gains Support From 360 Sportspeople: Why Are They Urging UK PM To Act?

The consequences of the consortium's closure extend well beyond clinical trial enrolment and patient welfare. At St. Jude Children's Research Hospital, 27 years of research data involving more than 2,000 children with rare brain tumours had to be archived.

Hundreds of biological samples, including tumour tissue, blood and spinal fluid collected from patients, also had to be returned to hospitals or destroyed if they could not be retained.

Researchers have raised concerns that losing the consortium's dedicated infrastructure and centralised data-access system could make it harder for scientists to resume these studies and build on previous findings.

Ira Dunkel, a paediatric oncologist at Memorial Sloan Kettering Cancer Center and former chair of the consortium, described the closure as “catastrophic” and one of the worst professional moments of his career.

Why Did The US Government Shut Down PBTC?

The NCI said the decision was taken to improve efficiency by moving the consortium's data into the larger Pediatric Early Phase Clinical Trials Network. The institute also said enrolment in some consortium studies had slowed.

But researchers argued that the smaller patient populations and the highly targeted nature of experimental treatments make specialised research areas particularly important.

After the decision, NCI announced that approximately $4 million would be allocated to the larger network to strengthen paediatric brain tumour research and accelerate Phase 1 clinical trials.

The $4 million grant also seemed insufficient compared to the $732 million that the NIH spends annually on childhood cancer. But according to Dunkel, it was “hugely important”.

But researchers and patient support groups have questioned whether the larger network can immediately and effectively replace the consortium's specialised expertise, proven collaborations and research infrastructure.

A bipartisan group of lawmakers from New York called wrote to Health and Human Services Secretary Robert F. Kennedy Jr., urging to reverse the decision. “We cannot afford to take this step backward,” the group said.

Families dealing with aggressive childhood brain cancers are helpless in the light of consortium closure. With some children having less than a year after diagnosis, such setbacks mean losing access to potentially life-saving or extending experimental treatment opportunities that may not become available again in time.

End of Article

India Moves Into The Trajectory Of Developed World, Doubles Social Security Expenditure In A Decade

Updated Nov 17, 2026 | 04:15 PM IST

SummaryThe National Health Accounts (NHA) Estimates for India 2023–24 revealed that government health expenditure more than tripled over the past decade, rising from ₹1,29,778 crore in 2013–14 to ₹4,14,196 crore in 2023–24.
India Moves Into The Trajectory Of Developed World, Doubles Social Security Expenditure In A Decade

Credit: AI Image

India’s social security expenditure on health nearly doubled as a share of Total Health Expenditure, rising from 6% in 2013–14 to 11% in 2023–24, according to the Union Health Ministry. The spending, estimated to have crossed Rs 1 lakh crore, aims to protect individuals and families against the financial risks associated with medical treatment.

This growth has been led by whopping contributions of the government's flagship health insurance schemes such as Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB PM-JAY), state-specific health insurance schemes, social health insurance and medical expenditure for government employees.

Private health insurance expenditure also increased, rising from 3.4% of Total Health Expenditure in 2013-14 to 10.2% in 2023-24.

Government Health Expenditure Triples In A Decade

Also read: Ayushman Bharat Turns 8: PM Modi Highlights Record Savings On Medical Expenses

According to the National Health Accounts (NHA) Estimates for India 2023-24, released by the Ministry of Health and Family Welfare, India’s government health expenditure nearly tripled over the past decade, increasing from Rs 1,29,778 crore in 2013-14 to Rs 4,14,196 crore in 2023-24.

The government’s share of Total Health Expenditure (THE) increased by 14.9 percentage points over the decade, representing a rise of nearly 52%.

The report also highlighted an increase in per-capita government health expenditure and a decline in households’ out-of-pocket spending on healthcare.

“A healthier India. Lower financial burden. Stronger healthcare for all!” Union Health Minister JP Nadda said in a post on X while sharing the data.

"The National Health Accounts 2023–24 tell a powerful story of India’s healthcare transformation over the last decade," he added.

India Moves Into The Trajectory Of Developed World, Doubles Social Security Expenditure In A Decade

Per-Capita Government Health Spending Rises 184% In A Decade

Per-capita government health expenditure increased by 184% over the decade, nearly tripling from Rs 1,042 in 2013-14 to Rs 2,959 in 2023-24.

Spending crossed Rs 2,000 in 2019-20, reaching Rs 2,014, and rose further to Rs 2,328 in 2020-21.

The highest per-capita expenditure was recorded in 2021-22 at Rs 3,169, driven by emergency COVID-19 spending. It subsequently declined by 12.1% to Rs 2,786 in 2022-23 before increasing by 6.2% to Rs 2,959 in 2023-24.

The year-on-year growth rate peaked at 36.1% in 2021-22. Among the years that recorded an increase, the lowest growth was 6.2% in 2023-24.

“These are not just numbers. They reflect a decade of sustained efforts to make quality healthcare more affordable,” Nadda said.

He attributed the progress to initiatives such as Ayushman Bharat and Ayushman Arogya Mandirs under Prime Minister Narendra Modi. He also highlighted expanded access to free medicines and diagnostics as part of efforts to strengthen healthcare delivery.

"Our commitment is simple: No family should have to choose between its health and its financial well-being. A Swasth Bharat is the foundation of a Viksit Bharat!" Nadda said.

Public Investment In Primary Healthcare Triples

Public investment in primary healthcare also nearly tripled over the decade, rising from Rs 50,010 crore in 2013-14 to Rs 1,52,771 crore in 2023-24, according to the NHA estimates.

Out-Of-Pocket Health Expenditure Falls

Read More: India Digitalizes Health Records Of 100 Crore People Under Ayushman Bharat

The share of out-of-pocket expenditure (OOPE) in Total Health Expenditure declined from 64.2% in 2013-14 to 42.7% in 2023-24, a drop of 21.5 percentage points.

This indicates that households are paying a smaller share of overall healthcare costs directly, while other financing sources, including government spending and health insurance, account for a larger share.

Government Initiatives Expanding Access To Affordable Healthcare

The Ministry also highlighted several initiatives aimed at improving access to affordable healthcare across the country. These include:

  • Free Drugs and Diagnostics Initiatives
  • Pradhan Mantri National Dialysis Programme
  • Pradhan Mantri Bhartiya Janaushadhi Pariyojana
  • Affordable Medicines and Reliable Implants for Treatment (AMRIT) pharmacies.

End of Article